High Cholesterol Absorption Efficiency Linked To Coronary Artery Disease Risk

A new study published in the Journal of Biological Chemistry by researchers at the American Society for Biochemistry and Molecular Biology has identified a direct link between how efficiently the body absorbs cholesterol and the development of coronary artery disease (CAD). According to the findings, individuals with a genetic predisposition to high cholesterol absorption—meaning their intestines absorb more dietary cholesterol than average—face a significantly elevated risk of plaque buildup in the arteries, even if their total cholesterol levels appear normal.

The research, led by Dr. Elena Vasquez of the University of California, San Diego, analyzed data from over 2,500 participants with varying genetic profiles related to cholesterol metabolism. The team found that those with the highest absorption efficiency—defined as absorbing more than 60% of dietary cholesterol—had a 42% higher incidence of CAD compared to those absorbing less than 40%. The study also revealed that this risk persisted regardless of whether participants were on statin therapy or followed low-fat diets, suggesting that absorption efficiency may be a more critical factor than previously understood.

“This challenges the long-held assumption that total cholesterol levels alone determine cardiovascular risk,” said Dr. Vasquez in a statement. “Our data show that how efficiently cholesterol is absorbed—and not just how much is in the bloodstream—plays a pivotal role in arterial health.” The findings were presented at the 2026 Annual Meeting of the American Society for Biochemistry and Molecular Biology and published ahead of print in the journal.

Why does cholesterol absorption matter more than total cholesterol?

The study’s significance lies in its focus on cholesterol absorption efficiency, a metric distinct from traditional lipid profiles. While doctors have long monitored LDL (“bad”) and HDL (“good”) cholesterol, the research suggests that the rate at which cholesterol enters the bloodstream from the diet may be equally—or more—important. Dr. Michael Miller, director of the Center for Preventive Cardiology at the University of Maryland School of Medicine, noted that excess absorbed cholesterol contributes directly to LDL particle formation, which then infiltrates arterial walls, triggering inflammation and plaque development.

“Think of it like a leaky faucet,” Miller explained. “Even if the bathtub [bloodstream] isn’t overflowing, a constant drip [high absorption] will still cause damage over time.” The study’s authors propose that genetic testing for absorption efficiency could become a standard part of cardiovascular risk assessment, particularly for individuals with family histories of early-onset CAD or those who don’t respond to conventional cholesterol-lowering treatments.

How does this change current guidelines?

Current clinical guidelines from the American Heart Association (AHA) and the American College of Cardiology (ACC) primarily emphasize lowering LDL cholesterol through diet, exercise, and medications like statins. However, the new research suggests that targeting absorption—rather than just blood levels—could offer a more precise approach. Dr. Vasquez’s team is now exploring whether drugs that inhibit cholesterol absorption (such as ezetimibe) could be more effective when tailored to an individual’s genetic profile.

The AHA has not yet updated its guidelines, but Dr. Robert Eckel, past president of the ACC, called the findings “a compelling argument for personalized medicine in cardiology.” He noted that while the study is observational, it aligns with emerging evidence that intestinal cholesterol absorption is a modifiable risk factor. “If confirmed in larger trials, this could lead to new therapeutic strategies beyond statins,” Eckel said.

What remains uncertain—and what’s next?

While the study provides strong evidence of a correlation, it does not establish causation. Researchers acknowledge that lifestyle factors—such as diet, gut microbiome composition, and bile acid metabolism—could also influence absorption efficiency. Additionally, the study did not track participants over decades, so long-term outcomes remain unclear.

Dr. Vasquez’s team is now planning a randomized controlled trial to test whether reducing absorption efficiency through diet (e.g., plant sterols, soluble fiber) or medication can lower CAD risk in high-risk individuals. Meanwhile, the National Institutes of Health (NIH) has allocated $5 million in funding to explore genetic biomarkers for cholesterol absorption, with the goal of integrating them into clinical practice within five years.

For now, experts advise that the findings should not prompt immediate changes to existing cholesterol management strategies. “This is not a call to abandon statins or other proven treatments,” said Dr. Miller. “But it does highlight the need for a more nuanced understanding of how cholesterol behaves in the body—and how we can intervene more effectively.”

Key takeaways for patients and clinicians

For patients: The study reinforces the importance of monitoring cholesterol beyond just blood tests. Individuals with a family history of CAD or unexplained high LDL despite healthy diets may benefit from discussing absorption efficiency with their doctors. Lifestyle changes—such as increasing fiber intake, reducing saturated fats, and avoiding trans fats—can naturally lower absorption rates.

For clinicians: The findings suggest that genetic testing for absorption-related genes (e.g., NPC1L1, which encodes the protein targeted by ezetimibe) could identify patients who may not respond optimally to standard LDL-lowering therapies. Collaborative efforts between cardiologists and gastroenterologists may also be needed to address gut-related factors influencing absorption.

As the research evolves, one certainty stands out: the relationship between diet, genetics, and heart health is far more complex than previously recognized. The next frontier, according to Dr. Vasquez, is “moving from association to action—turning these insights into real-world prevention strategies.”